PS4
Featured Poster Session IV: Cancer in the Elderly & Underserved Populations
Monday, March 24, 2014: 7:00 AM-8:00 AM
Ballroom A (Tampa Convention Center)
Description:
Featured Poster Session Moderator: Marcela del Carmen, MD, MPH, Massachusetts General Hospital/Harvard University, Boston, MA
7:00 AM
Moderator Introductions
M. del Carmen
Massachusetts General Hospital/Harvard University, Boston, MA
7:05 AM
Dose delay, but not dose reduction, in chemotherapy administration is associated with decreased survival in elderly women with ovarian cancer
N. Joseph1, R. M. Clark2, M. Lee3, K. Kopecky4, D. S. Dizon2 and W. B. Growdon3
1Brigham and Women's Hospital/Harvard University, Boston, MA, 2Massachusetts General Hospital/Harvard University, Boston, MA, 3Massachusetts General Hospital, Boston, MA, 4Harvard Medical School, Boston, MA
7:13 AM
Risk factors and impact of refusing recommended therapy in cervical cancer: a National Cancer Data Base (NCDB) study
J. F. Lin1, M. Rowland1, M. M. Boisen1, S. Beriwal1, S. D. Richard2, T. C. Krivak3 and P. Sukumvanich1
1Magee-Womens Hospital of UPMC, Pittsburgh, PA, 2Hahnemann University Hospital/Drexel University College of Medicine, Philadelphia, PA, 3Western Pennsylvania Hospital, Pittsburgh, PA
7:15 AM
Discussant in Featured Poster Session: Featured Poster Session IV: Cancer in the Elderly & Underserved Populations
C. A. Leath III
University of Alabama at Birmingham, Birmingham, AL
7:28 AM
Characteristics of high-volume gynecologic cancer centers – framework toward centers of excellence: a National Cancer Data Base (NCDB) study
J. F. Lin1, A. L. Alexander1, S. Beriwal1, T. C. Krivak2, R. E. Bristow3, B. J. Monk4, J. L. Kelley III1, A. B. Olawaiye1 and P. Sukumvanich1
1Magee-Womens Hospital of UPMC, Pittsburgh, PA, 2Western Pennsylvania Hospital, Pittsburgh, PA, 3University of California, Irvine, Irvine, CA, 4University of Arizona Cancer Center, Phoenix, AZ
7:30 AM
Discussant
K. Behbakht
University of Colorado Denver, Aurora, CO
7:35 AM
The role of adjuvant radiation and chemoradiation in single node-positive vulvar cancer
R. A. Laskey1, M. S. Ross1, J. F. Lin1, P. Sukumvanich1, T. C. Krivak2, J. T. Comerci1, M. Huang1, J. L. Kelley III1, A. B. Olawaiye1 and S. Beriwal1
1Magee-Womens Hospital of UPMC, Pittsburgh, PA, 2Western Pennsylvania Hospital, Pittsburgh, PA
7:37 AM
Barriers to human papillomavirus (HPV) vaccination: perspectives of parents of vaccine-eligible children
L. A. Meyer1, B. Brimmage2, M. P. Gomez3, S. Robazetti3, J. L. Dalrymple3, A. Gregg3 and M. S. Barratt3
1The University of Texas MD Anderson Cancer Center, Houston, TX, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3The University of Texas Medical School at Houston, Houston, TX
7:39 AM
Human papillomavirus vaccination within a Southern California integrated healthcare system demonstrates disparities in adherence rates among males and females compared to national reports
G. K. Forde1, D. Tewari2, C. Hong2, N. Rodriguez2, R. E. Bristow3 and K. S. Tewari4
1University of California at Irvine Medical Center, Orange, CA, 2Southern California Permanente Medical Group, Irvine, CA, 3University of California, Irvine, Irvine, CA, 4UC Irvine Medical Center, Orange, CA
7:43 AM
Discussant
D. K. Singh
Banner MD Anderson Cancer Center, Gilbert, AZ
7:48 AM
Question & Floor Discussion